Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $37.1 Million - $42.2 Million
479,662 Added 104.77%
937,496 $77.8 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $28.5 Million - $41 Million
457,834 New
457,834 $39.3 Million
Q2 2021

Aug 06, 2021

SELL
$63.47 - $69.35 $5.86 Million - $6.41 Million
-92,374 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $2.67 Million - $3.05 Million
44,483 Added 92.88%
92,374 $5.97 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $2.71 Million - $3.09 Million
47,891 New
47,891 $2.79 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $564,484 - $723,022
-9,013 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $177,403 - $195,138
2,879 Added 46.94%
9,013 $586,000
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $1.37 Million - $1.52 Million
-21,971 Reduced 78.17%
6,134 $389,000
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $1.11 Million - $1.24 Million
17,890 Added 175.13%
28,105 $1.9 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $2.1 Million - $2.35 Million
-33,529 Reduced 76.65%
10,215 $664,000
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $2.3 Million - $3 Million
37,961 Added 656.42%
43,744 $2.74 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $146,337 - $162,022
2,053 Added 55.04%
5,783 $447,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $105,624 - $123,207
-1,628 Reduced 30.38%
3,730 $264,000
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $1.88 Million - $2.29 Million
-25,763 Reduced 82.78%
5,358 $404,000
Q4 2017

Feb 14, 2018

BUY
$71.15 - $83.52 $2.21 Million - $2.6 Million
31,121
31,121 $2.23 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.